美国肿瘤血液与心血管疾病专题研究报告2009年10月
介绍
Table of Contents
Expected Upcoming Milestones for Our Oncology/Hematology Companies Under Coverage .... 1
Expected Upcoming Milestones for Our Cardiovascular Companies Under Coverage ................... 3
Recent and Upcoming Scientific/Medical Conferences ................ 4
Investment Risks ..................................................................... 6
Companies Under Coverage in the Oncology/Hematology Space
Alexion Pharmaceuticals ................................................... 7
Allos Therapeutics .............................................................. 9
AMAG Pharmaceuticals ..................................................... 11
Antisoma ………………...................................................... 13
ArQule ………………...................................................... 15
Celldex Therapeutics ……………….. .................................. 17
Dendreon ……………….. ............................................. 19
Geron ………………….................................................. 21
Poniard Pharmaceuticals ..................................................... 23
Regeneron Pharmaceuticals........................................................... 25
Seattle Genetics ………………........................................................... 27
Telik …………………….. ......................................................... 29
Companies Under Coverage in the Cardiovascular Disease Space
Cytokinetics ……………….. ........................................ 31
Dyax ……………….. ............................................................. 33
Isis Pharmaceuticals ……………………………….…..………………... 35
|
下载地址
------分隔线----------------------------